Skip to main content
Premium Trial:

Request an Annual Quote

LGC Buys KBioscience

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK science services firm LGC today announced it has acquired KBioscience for an undisclosed amount.

LGC's Genomics division and KBioscience will be combined to offer genomic services and solutions, LGC said. KBioscience provides genotyping services, chemistries, and related products, and the acquisition extends and LGC's genomics services and products.

The deal also further's LGC Genomics' goal to become Europe's leading provider of genomic services, LGC added.

Based in the UK, KBioscience was founded in 2002 and develops genotyping assays using its fluorescence-based competitive allele-specific PCR technique called KASP. LGC's products and services in DNA sequencing and extraction are complementary to the systems and products developed by KBioscience.

Its founders remain partners and significant shareholders in the company, LGC said.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.